Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses
- PMID: 7666544
- PMCID: PMC189543
- DOI: 10.1128/JVI.69.10.6430-6438.1995
Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses
Abstract
The CA (capsid) protein of avian sarcoma and leukemia viruses occurs in multiple species. Only one form has been previously characterized biochemically. We have now determined that the mature CA protein of avian sarcoma and leukemia viruses exists as three species with different C termini, ending in amino acid residues A-476, A-478, and M-479 of the Gag precursor, respectively. These structures were deduced from a combination of cyanogen bromide peptide mapping, sequence analysis of tryptic peptides, and electrospray mass spectrometry. The three forms of CA were detected in the same ratios in Rous sarcoma virus and avian myeloblastosis virus and therefore are likely to represent a common feature of members of this genus of avian retroviruses. The only previously reported CA species, CAM-479, accounts for only about 36% of the total CA protein, while CAA-476 and CAA-478 account for 55 and 9%, respectively. From the analysis of peptides cleaved in vitro by PR, the viral protease, we infer that the cleavage site between A-476 and A-477 not only is recognized by PR but is the preferred site. We were unable to determine if A-478/A-479 is a cleavage site for PR or alternatively if CAA-478 results from further processing of CAM-479 by a carboxypeptidase. To study the biological significance of residues A-477 to M-479, we constructed genetically altered viruses in which deletions removed either residues 477 to 479 or 477 to 488. The resulting virus particles appeared to assembly with normal efficiencies, but the latter mutant showed slowed proteolytic processing. Neither of the mutants was infectious.
Similar articles
-
Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.J Virol. 1997 Mar;71(3):2083-91. doi: 10.1128/JVI.71.3.2083-2091.1997. J Virol. 1997. PMID: 9032340 Free PMC article.
-
Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.J Virol. 1996 May;70(5):3313-8. doi: 10.1128/JVI.70.5.3313-3318.1996. J Virol. 1996. PMID: 8627817 Free PMC article.
-
Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.J Virol. 1997 Jan;71(1):444-50. doi: 10.1128/JVI.71.1.444-450.1997. J Virol. 1997. PMID: 8985369 Free PMC article.
-
Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping.J Virol. 1984 Oct;52(1):145-53. doi: 10.1128/JVI.52.1.145-153.1984. J Virol. 1984. PMID: 6090691 Free PMC article.
-
Phosphorylation of avian retrovirus matrix protein by Ca2+/phospholipid-dependent protein kinase.Eur J Biochem. 1989 Feb 1;179(2):415-22. doi: 10.1111/j.1432-1033.1989.tb14569.x. Eur J Biochem. 1989. PMID: 2537209
Cited by
-
The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.J Virol. 2015 Oct;89(20):10294-302. doi: 10.1128/JVI.01502-15. Epub 2015 Jul 29. J Virol. 2015. PMID: 26223638 Free PMC article.
-
Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.J Virol. 2010 Feb;84(4):1977-88. doi: 10.1128/JVI.02022-09. Epub 2009 Dec 9. J Virol. 2010. PMID: 20007269 Free PMC article.
-
Genetic determinants of Rous sarcoma virus particle size.J Virol. 1998 Jan;72(1):564-77. doi: 10.1128/JVI.72.1.564-577.1998. J Virol. 1998. PMID: 9420260 Free PMC article.
-
Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.J Virol. 1997 Mar;71(3):2083-91. doi: 10.1128/JVI.71.3.2083-2091.1997. J Virol. 1997. PMID: 9032340 Free PMC article.
-
Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivity.J Virol. 2001 Jul;75(13):6016-21. doi: 10.1128/JVI.75.13.6016-6021.2001. J Virol. 2001. PMID: 11390603 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials